ADAM17 and coronary artery disorder: Increased shedding of ACE2 due to activation of the renin–angiotensin system following upregulation of ADAM-17 also drives the pathogenesis in diseases such as heart failure and coronary artery disease(46), and elevated plasma sACE concentration is associated with a greater risk of major CVD events(47).